Yao-Chin Hsu

Yao-Chin Hsu


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YLYing-Ting Lin
Ying-Ting Lin
YWYu-Hsuan Wu
Yu-Hsuan Wu
CTChin-Kai Tseng
Chin-Kai Tseng
CLChun-Kuang Lin
Chun-Kuang Lin
WCWei-Chun Chen
Wei-Chun Chen
JLJin-Ching Lee
Jin-Ching Lee
Chronic hepatitis C virus (HCV) infection is the leading risk factor for hepatocellular carcinoma (HCC) and chronic liver disease worldwide. Green tea, in addition to being consumed as a healthy beverage, contains phenolic catechins that have been used as medicinal substances. In the present study, we illustrated that the epicatechin isomers (+)-epicatechin and (−)-epicatechin concentration-dependently inhibited HCV replication at nontoxic concentrations by using in vitro cell-based HCV replicon and JFH-1 infectious systems. In addition to significantly suppressing virus-induced cyclooxygenase-2 (COX-2) expression, our results revealed that the anti-HCV activity of the epicatechin isomers occurred through the down-regulation of COX-2. Furthermore, both the epicatechin isomers additively inhibited HCV replication in combination with either interferon-α or viral enzyme inhibitors [2′-C-methylcytidine (NM-107) or telaprevir]. They also had prominent anti-inflammatory effects by inhibiting the gene expression of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and inducible nitrite oxide synthase as well as the COX-2 in viral protein-expressing hepatoma Huh-7 cells. Collectively, (+)-epicatechin and (−)-epicatechin may serve as therapeutic supplements for treating HCV-related diseases.

14 March 2015 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
RHRen-Jun Hsu
Ren-Jun Hsu
YHYao-Chin Hsu
Yao-Chin Hsu
SCShu-Pin Chen
Shu-Pin Chen
CFChia-Lynn Fu
Chia-Lynn Fu
JYJyh-Cherng Yu
Jyh-Cherng Yu
CYCheng-Ping Yu
Cheng-Ping Yu
Breast cancer-related mortality increases annually. The efficacy of current breast cancer treatments is limited, and they have numerous side effects and permit high recurrence. Patients with estrogen receptor (ER)-negative or triple-negative breast cancer are particularly difficult to treat. Treatment for this type of cancer is lacking, and its prognosis is poor, necessitating the search for alternative treatments. This study screened Chinese herb Hibiscus syriacus extracts and identified a novel anti-cancer drug for patients with ER-negative breast cancer. The inhibitory effects on cell viability and migration were evaluated for each compound, and the molecular regulatory effects were evaluated on both mRNA and protein levels. We found several triterpenoids including betulin (K02) and its derivatives (K03, K04, and K06) from H. syriacus inhibited human triple-negative breast cancer cell viability and migration but revealed smaller cytotoxic effects on normal mammalian epithelial cells. Betulin and its derivatives induced apoptosis by activating apoptosis-related genes. In addition, they activated p21 expression, which induced cell cycle arrest in breast cancer cells. Betulin (K02) and betulinic acid (K06) had stronger inhibitory effects on cell viability and migration than K03 and K04. H. syriacus extracts might inhibit breast cancer cell viability and induce apoptosis by activating p53 family regulated pathways and inhibiting AKT activation. H. syriacus extracts may provide important insight into the development of novel alternative therapies for breast cancer.

11 April 2020 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
YSYu‐Chieh Su
Yu‐Chieh Su
YHYi‐Fang Huang
Yi‐Fang Huang
YWYu‐Wen Wu
Yu‐Wen Wu
HCHui‐Feng Chen
Hui‐Feng Chen
YWYu‐Hsuan Wu
Yu‐Hsuan Wu
JLJin-Ching Lee
Jin-Ching Lee
MicroRNAs (miRNAs) have been reported to directly alter the virus life cycle and virus–host interactions, and so are considered promising molecules for controlling virus infection. In the present study, we observed that miR‐155 time‐dependently downregulated upon dengue virus (DENV) infection. In contrast, exogenous overexpression of miR‐155 appeared to limit viral replication in vitro, suggesting that the low levels of miR‐155 would be beneficial for DENV replication. In vivo, overexpression of miR‐155 protected ICR suckling mice from the life‐threatening effects of DENV infection and reduced virus propagation. Further investigation revealed that the anti‐DENV activity of miR‐155 was due to target Bach1, resulting in the induction of the heme oxygenase‐1 (HO‐1)‐mediated inhibition of DENV NS2B/NS3 protease activity, ultimately leading to induction of antiviral interferon responses, including interferon‐induced protein kinase R (PKR), 2′‐5′‐oligoadenylate synthetase 1 (OAS1), OAS2, and OAS3 expression, against DENV replication. Collectively, our results provide a promising new strategy to manage DENV infection by modulation of miR‐155 expression.

8 May 2014 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
BCBi-Ying Chiu
Bi-Ying Chiu
CCChing-Ping Chang
Ching-Ping Chang
JLJia-Wei Lin
Jia-Wei Lin
JYJung-Sheng Yu
Jung-Sheng Yu
WLWen-Pin Liu
Wen-Pin Liu
MLMao-Tsun Lin
Mao-Tsun Lin

1 October 2014 in European Journal of Integrative Medicine
Verified
Journal Article
Closed access
JYJung-Sheng Yu
Jung-Sheng Yu
CHChung-Han Ho
Chung-Han Ho
YHYao-Chin Hsu
Yao-Chin Hsu
WJWang Jhi-Joung
Wang Jhi-Joung
CHChing-Liang Hsieh
Ching-Liang Hsieh

15 August 2013 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
PCPei-Shan Chien
Pei-Shan Chien
YTYu-Fang Tseng
Yu-Fang Tseng
YHYao-Chin Hsu
Yao-Chin Hsu
YLYu-Kai Lai
Yu-Kai Lai
SWShih-Feng Weng
Shih-Feng Weng
Background: Large-scale pharmaco-epidemiological studies of Chinese herbal medicine (CHM) for treatment of urticaria are few, even though clinical trials showed some CHM are effective. The purpose of this study was to explore the frequencies and patterns of CHM prescriptions for urticaria by analysing the population-based CHM database in Taiwan. Methods: This study was linked to and processed through the complete traditional CHM database of the National Health Insurance Research Database in Taiwan during 2009. We calculated the frequencies and patterns of CHM prescriptions used for treatment of urticaria, of which the diagnosis was defined as the single ICD-9 Code of 708. Frequent itemset mining, as applied to data mining, was used to analyse co-prescription of CHM for patients with urticaria. Results: There were 37,386 subjects who visited traditional Chinese Medicine clinics for urticaria in Taiwan during 2009 and received a total of 95,765 CHM prescriptions. Subjects between 18 and 35 years of age comprised the largest number of those treated (32.76%). In addition, women used CHM for urticaria more frequently than men (female:male = 1.94:1). There was an average of 5.54 items prescribed in the form of either individual Chinese herbs or a formula in a single CHM prescription for urticaria. Bai-Xian-Pi (Dictamnus dasycarpus Turcz) was the most commonly prescribed single Chinese herb while Xiao-Feng San was the most commonly prescribed Chinese herbal formula. The most commonly prescribed CHM drug combination was Xiao-Feng San plus Bai-Xian-Pi while the most commonly prescribed triple drug combination was Xiao-Feng San, Bai-Xian-Pi, and Di-Fu Zi (Kochia scoparia). Conclusions: In view of the popularity of CHM such as Xiao-Feng San prescribed for the wind-heat pattern of urticaria in this study, a large-scale, randomized clinical trial is warranted to research their efficacy and safety.